Vanguard Group Inc 89bio, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in 89bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,722,971 shares of ETNB stock, worth $37.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,722,971

Previous 4,307,585 9.64%

Holding current value

$37.8 Million

Previous $48.1 Million 14.26%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$8.13 - $13.77 $3.38 Million - $5.72 Million	415,386 Added 9.64%	4,722,971 $55 Million
Q4 2023 Feb 14, 2024	BUY	$6.66 - $16.03 $5.21 Million - $12.5 Million	781,803 Added 22.17%	4,307,585 $48.1 Million
Q3 2023 Nov 14, 2023	BUY	$15.06 - $19.41 $2.35 Million - $3.02 Million	155,841 Added 4.62%	3,525,782 $54.4 Million
Q2 2023 Aug 14, 2023	BUY	$14.15 - $22.03 $10.8 Million - $16.8 Million	763,656 Added 29.3%	3,369,941 $63.9 Million
Q1 2023 May 15, 2023	BUY	$10.48 - $16.94 $10.8 Million - $17.4 Million	1,027,990 Added 65.13%	2,606,285 $39.7 Million

Q4 2022 Feb 10, 2023	SELL	$7.81 - $12.73 $728,587 - $1.19 Million	-93,289 Reduced 5.58%	1,578,295 $20.1 Million
Q3 2022 Nov 14, 2022	BUY	$3.02 - $7.0 $2.06 Million - $4.78 Million	683,232 Added 69.13%	1,671,584 $9.68 Million
Q2 2022 Aug 12, 2022	BUY	$2.09 - $4.02 $1.22 Million - $2.34 Million	582,933 Added 143.79%	988,352 $3.18 Million
Q1 2022 May 13, 2022	SELL	$3.45 - $14.99 $382,001 - $1.66 Million	-110,725 Reduced 21.45%	405,419 $1.53 Million
Q4 2021 Feb 14, 2022	SELL	$11.15 - $19.66 $1.01 Million - $1.78 Million	-90,770 Reduced 14.96%	516,144 $6.75 Million
Q3 2021 Nov 12, 2021	BUY	$14.91 - $21.31 $2.61 Million - $3.73 Million	174,979 Added 40.51%	606,914 $11.9 Million
Q2 2021 Aug 13, 2021	BUY	$17.42 - $28.0 $7.52 Million - $12.1 Million	431,935 New	431,935 $8.08 Million

Others Institutions Holding ETNB

# of Institutions

164

Shares Held

89.1M

Call Options Held

584K

Put Options Held

1.17M

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $372M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc 89bio, Inc. Transaction History